Abstract
Introduction
Calcium is essential for muscle contraction, second messenger formation, secretion of neurotransmitters and hormones, blood coagulation, and bone metabolism. Its availability for these essential functions is dependent upon dietary intake of calcium and vitamin D as well as gut absorption and bone metabolism. In particular, uptake of calcium requires prior vitamin D uptake and metabolism.
Vitamin D is not merely a vitamin but a highly regulated steroid hormone system with several derivatives and metabolites. Vitamin D2 is a plantderived molecule that is ingested, whereas vitamin D3 is a derivative of cholesterol that can also be ingested or formed in the skin via ultraviolet light. Vitamin D is then converted in the liver to 25-hydroxyvitamin D (25(OH)D), which is the precursor of the active metabolite. Final conversion to the active metabolite, 1,25-dihydroxyvitamin D occurs in the kidney. Vitamin D then acts via the vitamin D receptor (VDR). Because the VDR is found in 37 different human tissues, vitamin D is linked to a multitude of biological and pathological processes. However, caution must be exercised in interpreting these studies until clear evidence for causality becomes available. The purpose of this article is to review some of the known vitamin D and calcium associations with clinical condition as well as the current guidelines for calcium and vitamin D supplementation in women of reproductive age. Maternal insufficiency of calcium and vitamin D correlates with fetal insufficiency. In the 2010 study by Karim et al, a positive correlation between the level of vitamin D in maternal serum and cord blood was found, with a high prevalence of both insufficiency (20-29ng/ml) and deficiency (<20ng/ml) in the maternal sample population. Fetal Vitamin D levels were categorized as sufficient (>33ng/ml) or deficient (<33ng/dl). This study was conducted on 50 consecutive women presenting in labor with a singleton term pregnancy at a tertiary care center in Pakistan. Maternal blood take prior to delivery was compared to cord blood at the time of delivery. Maternal deficiency was noted in 23 (46%) and insufficiency in 16 (32%) while fetal insufficiency was noted in 44 infants (88%). Maternal Vitamin D levels were significantly correlated to sunlight exposure and diet.(P<.0007). 2 
Defining calcium and vitamin D deficiency

A little history of vitamin D
The clinical presentation of rickets, which is caused by vitamin D deficiency, was first described in children in the mid-17 th century. Vitamin D deficiency was noted to cause lifelong bone deformities in weight bearing bones including the pelvis. In the early 19 th century in Glasgow, it was reported that one out of thirty deliveries required destruction of the fetal cranium because of a rachitic maternal pelvis. 3 In the British Medical Journal in 1890, Murdoch Cameron introduced c-sections into practice for women with a deformed pelvis. 4 An early 20 th century public health campaign greatly reduced the prevalence of vitamin D deficiency. Unfortunately, rickets has started to re-emerge in the pediatric literature, potentially because of the current practice of avoiding ultraviolet light to decrease the incidence of skin cancer.
The significance of calcium and vitamin D: classic ideas
Calcium is important for skeletal mineralization in the reproductive female. Sufficient maternal calcium intake is critical to maintain adequate circulating values and thereby avoid maternal skeletal depletion in pregnancy and lactation. Maternal calcium intake also affects circulating calcium levels in infants. Approximately 210 mg/day of calcium is secreted into the breast milk. The source of this maternal calcium is increased bone mineralization and decreased urinary excretion. Not surprisingly, a 2-5% loss in bone density occurs during pregnancy and lactation, but it rebounds with the resumption of menses. In addition to calcium, fat soluble vitamins (D, A, E) are also secreted into breast milk. Vitamin D levels in newborns (the first postnatal 6-8 weeks) are largely dependent upon pre-natal stores. Like with calcium, vitamin D levels in breast fed infants reflect maternal intake. Human breast milk has 20-60 IU/liter, which is 1.5-3% of the maternal levels of vitamin D. Therefore, it is recommended that all breast fed infants are supplemented with 400 IU of vitamin D daily. Another possible strategy to increase infant vitamin D intake is to increase maternal intake. In a small study of 18 women, 4000 IU maternal supplementation substantially increased the vitamin D content of breast milk.
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To attain the recommended daily allowance in formula fed infants, 400 IU/liter is added to all formula in the US.
Non Classical Associations
Preconception
Vitamin D is thought to be important in the preconception period. For example, animal studies demonstrate impaired fertility, likely attributed to abnormal ovulatory function, in vitamin D-deficient rats. 6 Mice devoid of α1-hydroxylase have hypoplastic reproductive organ development. 7 Finally, VDR null mice are infertile but develop normal fertility with a calcium-rich diet. 8 A prospective cohort study revealed that higher 25(OH)D levels in serum and follicular fluid predicted success of in vitro fertilization (IVF), even after adjustment for age, body mass index (BMI), ethnicity, and number of embryos. 9 Interestingly, there was no increase in ovulation, and the authors postulated that the increased levels of 25(OH)D improved receptivity and implantation.
Polycystic Ovarian Syndrome
While no randomized control trials have examined the effect of vitamin D and/or calcium supplementation in women with polycystic ovarian syndrome (PCOS), several small trials have demonstrated some improvements in PCOS patients with vitamin D and calcium treatment. Thys-Jacobs et al demonstrated that calcium and vitamin D (1500mg supplement) treatment normalized menstrual cycles in 54% (7/13) of women with PCOS. 10 In another study of 15 PCOS patients, insulin secretion was improved with vitamin D treatment. 11 A pilot study in which women were treated with metformin, calcium, and vitamin D, improved number dominant follicles >14mm were observed. 12 
Pre-eclampsia
The role of calcium in pre-eclampsia was first examined in the Calcium for Pre-Eclampsia Prevention Trial (CPEP) in 1997. 13 In this study, 4589 women at 13-21 weeks of gestation were randomized in a placebocontrolled double blinded trial to daily supplementation with 2000 mg calcium versus placebo for the remainder of pregnancy. Unfortunately, no difference was found in the development of gestational hypertension, preeclampsia, or adverse perinatal outcomes in healthy nulliparous women with or without calcium supplementation. In 2006, the World Health Organization reported results from a randomized placebocontrolled double blind trial of 8325 pregnant women with low calcium intake (< 600 mg/day) with calcium supplementation. 14 The subjects were enrolled prior to 20 gestational weeks and randomized to receive 1500 mg of calcium per day versus placebo for the duration of pregnancy. Supplementation did not prevent pre-eclampsia but it did reduce its severity, along with reducing maternal and neonatal morbidity. In a Cochrane database review of >15,000 women in 12 trials, supplementation with at least 1 gram of calcium daily during pregnancy compared to placebo reduced the risk of both gestational hypertension (RR 0.65) and preeclampsia (RR 0.45). 15 The women in a majority of the studies included in this meta-analysis could be categorized as having a low risk pregnancy as well as a low calcium diet. 18, 19 A third cross sectional study of Indian mothers found no association. 20 One prospective case controlled study demonstrated that vitamin D deficiency (24.2 vs 30.1 ng/ml) at 16 weeks of gestation was associated with increased risk for GDM development. 33% of gestational diabetic cases had Vitamin D levels <20ng/ml compared with 14% of controls. 21 
Mode of delivery, preterm birth, and low birth weight
To understand how vitamin D deficiency contributes to the mode of delivery, one study measured the maternal and neonatal 25(OH)D levels and found that women with deficiency in vitamin D were four times more likely to have a primary c-section. 22 The authors' explanation for this finding is related to the fact that skeletal muscle contains the vitamin D receptor such that vitamin D deficiency is associated with suboptimal muscle performance and strength.
With regards to birth weight, in the 1980's, the initial randomized controlled trial showed that vitamin D supplementation leads to fewer small for gestational age infants. 23 However, conflicting data from France reported no difference in birth weight between groups receiving 20,000 IU or 2000 IU vitamin D as compared to placebo. 24 However, maternal milk intake has been correlated with larger infants in two separate trials, one in Canada 25 and a larger cohort study in the Netherlands. 
